Designing clinical trials with (restricted) mean survival time endpoint: Practical considerations

对数秩检验 统计 临床终点 可解释性 样本量测定 时间点 生存分析 数学 临床试验 医学 计算机科学 内科学 机器学习 哲学 美学
作者
Anne Eaton,Terry M. Therneau,Jennifer Le‐Rademacher
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:17 (3): 285-294 被引量:29
标识
DOI:10.1177/1740774520905563
摘要

Background/aims: The difference in mean survival time, which quantifies the treatment effect in terms most meaningful to patients and retains its interpretability regardless of the shape of the survival distribution or the proportionality of the treatment effect, is an alternative endpoint that could be used more often as the primary endpoint to design clinical trials. The underuse of this endpoint is due to investigators’ lack of familiarity with the test comparing the mean survival times and the lack of tools to facilitate trial design with this endpoint. The aim of this article is to provide investigators with insights and software to design trials with restricted mean survival time as the primary endpoint. Methods: A closed-form formula for the asymptotic power of the test of restricted mean survival time difference is presented. The effects of design parameters on power were evaluated for the mean survival time test and log-rank test. An R package which calculates the power or the sample size for user-specified parameter values and provides power plots for each design parameter is provided. The R package also calculates the probability that the restricted mean survival time is estimable for user-defined trial designs. Results: Under proportional hazards and late differences in survival, the power of the mean survival time test can approach that of the log-rank test if the restriction time is late. Under early differences, the power of the restricted mean survival time test is higher than that of the log-rank test. Duration of accrual and follow-up have little influence on the power of the restricted mean survival time test. The choice of restriction time, on the other hand, has a large impact on power. Because the power depends on the interplay among the design factors, plotting the relationship between each design parameter and power allows the users to select the designs most appropriate for their trial. When modification is necessary to ensure the difference in restricted mean survival time is estimable, the three available modifications all perform adequately in the scenarios studied. Conclusion: The restricted mean survival time is a survival endpoint that is meaningful to investigators and to patients and at the same time requires less restrictive assumptions. The biggest challenge with this endpoint is selection of the restriction time. We recommend selecting a restriction time that is clinically relevant to the disease and the clinical setting of the trial of interest. The practical considerations and the R package provided in this work are readily available tools that researchers can use to design trials with restricted mean survival time as the primary endpoint.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
苏silence发布了新的文献求助10
1秒前
1秒前
1秒前
2秒前
2秒前
小冰棍完成签到,获得积分10
2秒前
量子星尘发布了新的文献求助10
3秒前
3秒前
大脸完成签到,获得积分10
4秒前
wawaeryu完成签到,获得积分10
4秒前
4秒前
莉123发布了新的文献求助10
4秒前
5秒前
苏打发布了新的文献求助10
5秒前
共享精神应助顺心的惜蕊采纳,获得10
5秒前
6秒前
桐桐应助Kalmia采纳,获得10
6秒前
6秒前
星星子发布了新的文献求助10
7秒前
火星发布了新的文献求助20
7秒前
7秒前
9秒前
华健完成签到,获得积分20
9秒前
vicky发布了新的文献求助10
9秒前
阿龙完成签到,获得积分10
10秒前
10秒前
YYY完成签到,获得积分10
10秒前
关关完成签到,获得积分20
10秒前
huan_xii应助Okayoooooo采纳,获得20
10秒前
心灵美的若风完成签到,获得积分20
11秒前
11秒前
11秒前
慕青应助细心的靖巧采纳,获得30
12秒前
zzzz完成签到,获得积分10
13秒前
马明旋发布了新的文献求助10
13秒前
13秒前
zn发布了新的文献求助10
13秒前
moyue完成签到,获得积分10
14秒前
图图烤肉发布了新的文献求助10
14秒前
Ing发布了新的文献求助10
14秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974882
求助须知:如何正确求助?哪些是违规求助? 3519431
关于积分的说明 11198315
捐赠科研通 3255698
什么是DOI,文献DOI怎么找? 1797904
邀请新用户注册赠送积分活动 877237
科研通“疑难数据库(出版商)”最低求助积分说明 806219